Inorg. Chem. 2003, 42, 929−931
A Mono-Diazenide Complex from Perrhenate: Toward a New Core for
Rhenium Radiopharmaceuticals
,‡
Andrew R. Cowley,† Jonathan R. Dilworth,* and Paul S. Donnelly‡
Inorganic Chemistry Laboratory, UniVersity of Oxford, South Parks Road, Oxford, U.K. OX1 3QR,
and Chemical Crystallography Laboratory, UniVersity of Oxford, U.K.
Received September 3, 2002
A new method for the synthesis of low to intermediate oxidation
state rhenium complexes containing a bifunctional ligand has been
This methodology has been used successfully in the
development of 99mTc imaging agents which use N-oxysuc-
cinimidylhydrazinonicotinamide (HYNIC) as the bifunctional
ligand.9,10 Similar systems have been investigated with
rhenium, whose coordination chemistry is superficially
similar to technetium, although rhenium is more kinetically
inert than technetium and significantly it is much harder to
reduce [ReO4]- than it is [TcO4]-.1 The coordination
chemistry of the HYNIC system is shown by the reaction of
[ReO4]- with 2-hydrazinopyridine which gives systems in
which two pyridylhydrazine derived units are coordinated
to the rhenium.11-13 X-ray structural characterization of the
compounds formed revealed a complex coordination chem-
istry due to the ability of the pyridylhydrazine derived ligands
to coordinate as either monodentate or bidentate ligands and
the existence of protic equilibria.14 This results in radiolabeled
protein conjugates made using this system consisting of
mixtures of complexes which have proved difficult to
characterize fully.
developed. Reaction of [ReO ]- with substituted phenylhydrazines
4
and triphenylphosphine in acetonitrile in the presence of HCl allows
the isolation of [ReCl2(NNC H -4-R)(NCCH )(PPh3)2] (where R )
6
4
3
OCH , Cl, or CO CH ). The substituted hydrazine acts as both a
3
2
3
reductant and source of a monodentate diazenide ligand. The
compounds have all been characterized in the solid state by X-ray
crystallography and in the solution state by NMR, electrospray
mass spectrometry, and HPLC. Cyclic voltammetry measurements
show that the mono-diazenide complexes undergo a reversible
oxidation.
There is much interest in the development of new
radiotherapeutic cancer agents based on rhenium. There are
two â-emitting isotopes of Re, 186Re and 188Re, which have
suitable nuclear properties for therapeutic applications. 188Re
is readily available from a generator by decay of 188W and
is obtained as a very dilute solution of [ReO4]-.1,2 This can
provide a useful source of sterilizing â radiation if it can be
targeted in vivo.3 Such targeting can be achieved by the
incorporation of the metal atom in a coordination complex
using a bifunctional ligand. Ideally the ligand must form a
highly stable complex and possess a point of further
functionalization that can allow the attachment of biologically
active molecules4 to provide specificity and selectivity in
vivo.1,5-8
We have previously reported the reaction of [ReOCl3-
(PPh3)2] with arylhydrazines (ArNHNH2) in methanol to give
the bis(diazenido) complexes [ReCl(N2Ar)2(PPh3)2].15 How-
ever, the substitution chemistry of these, like the pyridyl-
hydrazine derivatives, is complicated by protic equilibria and
somewhat unpredictable loss of diazenide with some ligand
systems. We here report the reaction of arylhydrazines
directly with perrhenate in acetonitrile to give a high yield
of a mono aryl diazenide complex. This undergoes extensive
high-yield substitution reactions16 and has the potential to
* Author to whom correspondence should be addressed. E-mail:
(9) Liu, S.; Edwards, D. S.; Barrett, J. A. Bioconjugate Chem. 1997, 8,
621.
(10) Babich, J. W.; Coco, W. G.; Barrow, S.; Fischman, A. J.; Femia, F.
L.; Zubieta, J. Inorg. Chim. Acta 2000, 309, 123.
† Chemical Crystallography Laboratory.
‡ Inorganic Chemistry Laboratory.
(1) Dilworth, J. R.; Parrott, S. J. Chem. Soc. ReV. 1998, 27, 43.
(2) Blower, P. J.; Dilworth, J. R.; Maurer, R. I.; Mullen, G. D.; Reynolds,
C. A.; Zheng, Y. J. Inorg. Biochem. 2001, 85, 15.
(3) Volkert, W. A.; Hoffman, T. J. Chem. ReV. 1999, 99, 2269.
(4) Rader, C.; List, B. Chem. Eur. J. 2000, 6, 2091.
(5) Parker, D. In ComprehensiVe Supramolecular Chemistry; Reinhoudt,
D. N., Ed.; Pergamon Press: Cambridge, 1996; Vol. 10.
(6) Reichert, D. E.; Lewis, J. S.; Anderson, C. J. Coordin. Chem. ReV.
1999, 184, 3.
(11) Nicholson, T.; Cook, J.; Davison, A.; Rose, D. J.; Maresca, K. P.;
Zubieta, J.; Jones, A. G. Inorg. Chim. Acta 1996, 252, 421.
(12) Nicholson, T.; Cook, J. D.; Davison, A.; Rose, D. J.; Maresca, K. P.;
Zubieta, J.; Jones, A. G. Inorg. Chim. Acta 1996, 252, 427.
(13) Hirsch-Kuchma, M.; Nicholson, T.; Davison, A.; Davis, W. M.; Jones,
A. G. Inorg. Chem. 1997, 36, 3237.
(14) Rose, D. J.; Maresca, K. P.; Nicholson, T.; Davison, A.; Jones, A.
G.; Babich, J. W.; Fischman, A. J.; Graham, W.; DeBord, J. R. D.;
Zubieta, J. Inorg. Chem. 1998, 37, 2701.
(7) Jurisson, S.; Berning, D.; Jia, W.; Ma, D. Chem. ReV. 1993, 93, 1137.
(8) Anderson, C. J.; Welch, M. J. Chem. ReV. 1999, 99, 2219.
(15) Dilworth, J. R.; Harrison, S. A.; Walton, D. R. M.; Schweda, E. Inorg.
Chem. 1985, 24, 2594.
10.1021/ic025995w CCC: $25.00 © 2003 American Chemical Society
Published on Web 01/29/2003
Inorganic Chemistry, Vol. 42, No. 4, 2003 929